AMS Bulking Out Stress Incontinence Offerings Via UroVive Acquisition
This article was originally published in The Gray Sheet
Executive Summary
American Medical Systems and UroSurge expect to complete by year-end a modular premarket approval application submission for the UroVive urethral bulking agent system. AMS agreed to acquire the product from UroSurge on July 26.
You may also be interested in...
AMS' Planned IPO Proceeds To Pay Down Debt, Complete Influence Payments
A planned initial public offering by American Medical Systems Holdings, Inc., maker of urological disorder treatment devices, is anticipated to raise $68.8 mil. -including $40 mil. tabbed to "repay all of the outstanding debt under the guaranteed portion" of a $115 mil. credit facility.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.